Maravai Lifesciences Holdings (MRVI) Non-Current Assets (2020 - 2026)

Maravai Lifesciences Holdings' Non-Current Assets history runs 7 years deep, the most recent figure standing at $461.5 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 20.91% year-over-year to $461.5 million; the TTM figure through Mar 2026 stood at $2.0 billion (down 20.9% YoY), while the FY2025 annual figure was $474.3 million, down 18.09% from the prior year.
• Non-Current Assets was $461.5 million for Q1 2026 at Maravai Lifesciences Holdings, down from $474.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.6 billion in Q3 2023 to a low of $461.5 million in Q1 2026.
• Historically, Non-Current Assets has averaged $967.7 million across 5 years, with a median of $776.8 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 53.75% in 2022, then sank 61.76% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $1.4 billion in 2022, then slumped by 45.1% to $787.5 million in 2023, then dropped by 26.47% to $579.1 million in 2024, then decreased by 18.09% to $474.3 million in 2025, then dropped by 2.71% to $461.5 million in 2026.
• The last three Non-Current Assets figures came in at $461.5 million (Q1 2026), $474.3 million (Q4 2025), and $523.3 million (Q3 2025), per Business Quant data.